Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior - A cohort study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Rieder, Florian ^a,b   Paul, Gisela ^a   Schnoy, Elisabeth ^a   Schleder, Stephan ^a   Wolf, Alexandra ^a   Kamm, Florian ^a   Dirmeier, Andrea ^a   Strauch, Ulrike ^a   Obermeier, Florian ^a   Lopez, Rocio ^b   Achkar, Jean Paul ^b   Rogler, Gerhard ^c   Klebl, Frank ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN;

ADULT; BLOOD; COHORT ANALYSIS; CROHN DISEASE; DISEASE COURSE; ERYTHROCYTE; FEMALE; HEMATOCRIT; HUMAN; MALE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

ADULT; BIOMARKERS; COHORT STUDIES; CROHN DISEASE; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84905833520     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104706     Document Type: Article

References (21)

1. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, et al. (2001) Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49: 777-782. (Pubitemid 33096034)
2. Rieder F, Brenmoehl J, Leeb S, Scholmerich J, Rogler G (2007) Wound healing and fibrosis in intestinal disease. Gut 56: 130-139. (Pubitemid 46044899)
3. Jess T, Riis L, Vind I, Winther KV, Borg S, et al. (2007) Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 13: 481-489. (Pubitemid 46668255)
4. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, et al. (2002) Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to autoand microbial antigens. Gastroenterology 123: 689-699. (Pubitemid 34977074)
5. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, et al. (2006) Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131: 366-378. (Pubitemid 44142445)
6. Rieder F, Schleder S, Wolf A, Dirmeier A, Strauch U, et al. (2010) Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflamm Bowel Dis 16: 263-274.
7. Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, et al. (2008) Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children. Clin Gastroenterol Hepatol 10: 1105-1111.
8. Amre DK, Lu SE, Costea F, Seidman EG (2006) Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am J Gastroenterol 101: 645-652. (Pubitemid 43340944)
9. Rieder F, Schleder S, Wolf A, Dirmeier A, Strauch U, et al. (2010) Serum antiglycan antibodies predict complicated Crohn's disease behavior: a cohort study. Inflamm Bowel Dis 16: 1367-1375.
10. Song CS, Park DI, Yoon MY, Seok HS, Park JH, et al. (2012) Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci 57: 1033-1038.
11. Yesil A, Senates E, Bayoglu IV, Erdem ED, Demirtunc R, et al. (2011) Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver 5: 460-467.
12. Cakal B, Akoz AG, Ustundag Y, Yalinkilic M, Ulker A, et al. (2009) Red cell distribution width for assessment of activity of inflammatory bowel disease. Dig Dis Sci 54: 842-847.
13. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, et al. (2010) The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 4: 7-27.
14. Mandrekar JN, Mandrekar SJ, Cha SS (2003) Cutpoint Determination Methods in Survival Analysis using SAS. Proceedings of the 28th SAS Users Group International Conference (SUGI) Paper 261.
15. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J (2006) Predictors of Crohn's disease. Gastroenterology 130: 650-656. (Pubitemid 43374514)
16. Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS (2004) Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 89: 69-71. (Pubitemid 38122017)
17. Cash JM, Sears DA (1989) The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. Am J Med 87: 638-644. (Pubitemid 20006501)
18. Vijverman A, Piront P, Belaiche J, Louis E (2006) Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 69: 1-4.
19. Wilson A, Reyes E, Ofman J (2004) Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 116 Suppl 7A: 44S-49S.
20. Kulnigg S, Gasche C (2006) Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 24: 1507-1523. (Pubitemid 44915199)
21. Semrin G, Fishman DS, Bousvaros A, Zholudev A, Saunders AC, et al. (2006) Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 12: 1101-1106. (Pubitemid 44847466)